BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33046892)

  • 21. [DGFIT: Immune and targeted therapy in urologic oncology – what can be expected?].
    Hegele A; Heinzer H; Rüttinger D; Siebels M
    Aktuelle Urol; 2012 Jul; 43(4):219-26. PubMed ID: 23035262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical implications of current developments in genitourinary pathology.
    Zhou AG; Owens CL; Cosar EF; Jiang Z
    Arch Pathol Lab Med; 2013 Jul; 137(7):887-93. PubMed ID: 23808460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer.
    Wang R; Wang L; Li Y; Hu H; Shen L; Shen X; Pan Y; Ye T; Zhang Y; Luo X; Zhang Y; Pan B; Li B; Li H; Zhang J; Pao W; Ji H; Sun Y; Chen H
    Clin Cancer Res; 2014 Aug; 20(15):4107-14. PubMed ID: 24850843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The discovery of common recurrent transmembrane protease serine 2 (TMPRSS2)-erythroblastosis virus E26 transforming sequence (ETS) gene fusions in prostate cancer: significance and clinical implications.
    Shah RB; Chinnaiyan AM
    Adv Anat Pathol; 2009 May; 16(3):145-53. PubMed ID: 19395877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal cell carcinomas with t(6;11)(p21;q12): A clinicopathologic study emphasizing unusual morphology, novel alpha-TFEB gene fusion point, immunobiomarkers, and ultrastructural features, as well as detection of the gene fusion by fluorescence in situ hybridization.
    Rao Q; Liu B; Cheng L; Zhu Y; Shi QL; Wu B; Jiang SJ; Wang Y; Wang X; Yu B; Zhang RS; Ma HH; Lu ZF; Tu P; Wang JD; Zhou XJ
    Am J Surg Pathol; 2012 Sep; 36(9):1327-38. PubMed ID: 22895266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xp11 Translocation Renal Cell Carcinomas (RCCs) With RBM10-TFE3 Gene Fusion Demonstrating Melanotic Features and Overlapping Morphology With t(6;11) RCC: Interest and Diagnostic Pitfall in Detecting a Paracentric Inversion of TFE3.
    Xia QY; Wang XT; Zhan XM; Tan X; Chen H; Liu Y; Shi SS; Wang X; Wei X; Ye SB; Li R; Ma HH; Lu ZF; Zhou XJ; Rao Q
    Am J Surg Pathol; 2017 May; 41(5):663-676. PubMed ID: 28288037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma.
    Zhong M; De Angelo P; Osborne L; Keane-Tarchichi M; Goldfischer M; Edelmann L; Yang Y; Linehan WM; Merino MJ; Aisner S; Hameed M
    Am J Surg Pathol; 2010 Jun; 34(6):757-66. PubMed ID: 20421778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-204-5p: A novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma.
    Kurahashi R; Kadomatsu T; Baba M; Hara C; Itoh H; Miyata K; Endo M; Morinaga J; Terada K; Araki K; Eto M; Schmidt LS; Kamba T; Linehan WM; Oike Y
    Cancer Sci; 2019 Jun; 110(6):1897-1908. PubMed ID: 31006167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
    Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
    Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: an adult case report and literature review.
    Wang Y; Wang Y; Feng M; Lian X; Lei Y; Zhou H
    J Int Med Res; 2020 Oct; 48(10):300060520942095. PubMed ID: 33026261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic pitfall on the histological spectrum of adult-onset renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.
    Kuroda N; Katto K; Tanaka Y; Yamaguchi T; Inoue K; Ohara M; Mizuno K; Hes O; Michal M; Lee GH
    Med Mol Morphol; 2010 Jun; 43(2):86-90. PubMed ID: 20683695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genitourinary cancer.
    Hudes GR; Grana G; Deshields MS; Ozols RF
    Cancer Chemother Biol Response Modif; 1992; 13():508-40. PubMed ID: 1389919
    [No Abstract]   [Full Text] [Related]  

  • 33. Xp11.2 translocation renal cell carcinoma with PSF-TFE3 rearrangement.
    Zhong M; Weisman P; Zhu B; Brassesco M; Yang Y; Linehan WM; Merino MJ; Zhang D; Rohan S; Cai D; Yang X
    Diagn Mol Pathol; 2013 Jun; 22(2):107-11. PubMed ID: 23628822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retention of Interstitial Genes between
    Murphy SJ; Kosari F; Karnes RJ; Nasir A; Johnson SH; Gaitatzes AG; Smadbeck JB; Rangel LJ; Vasmatzis G; Cheville JC
    Cancer Res; 2017 Nov; 77(22):6157-6167. PubMed ID: 29127096
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical applications of novel ERG immunohistochemistry in prostate cancer diagnosis and management.
    Shah RB
    Adv Anat Pathol; 2013 Mar; 20(2):117-24. PubMed ID: 23399797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perspectives on Geriatric Oncology Research presented at the 2019 American Society of Clinical Oncology Genitourinary Cancers Symposium.
    Shen J; Prentice M; Pollock Y; Franca M; Kanesvaran R
    J Geriatr Oncol; 2019 Jul; 10(4):523-525. PubMed ID: 30982753
    [No Abstract]   [Full Text] [Related]  

  • 37. Xp11 translocation renal cell carcinoma with morphological features mimicking multilocular cystic renal neoplasm of low malignant potential: a series of six cases with molecular analysis.
    Song Y; Yin X; Xia Q; Zheng L; Yao J; Zeng H; Nie L; Gong J; Zhou Q; Chen N
    J Clin Pathol; 2021 Mar; 74(3):171-176. PubMed ID: 32699116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
    Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
    Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genitourinary cancer.
    Ozols RF; Yagoda A
    Cancer Chemother Biol Response Modif; 1990; 11():602-29. PubMed ID: 2171615
    [No Abstract]   [Full Text] [Related]  

  • 40. Fibroblast growth factor receptor (
    Al-Obaidy KI; Cheng L
    J Clin Pathol; 2021 Aug; 74(8):491-495. PubMed ID: 33731335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.